Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
boston blog main
life sciences
national blog main
new york blog main
new york top stories
6
×
sanofi
6
×
boston top stories
clinical trials
fda
national top stories
new york
san francisco blog main
biotech
deals
san francisco top stories
alnylam pharmaceuticals
amgen
cancer
inclisiran
ipo
novartis
pcsk9
regeneron pharmaceuticals
startups
takeda pharmaceutical
abbvie
agios pharmaceuticals
akili interactive labs
akouos
alirocumab
allergan
amag pharmaceuticals
amunix
anirvan ghosh
astrazeneca
biogen
biontech
bluerock therapeutics
boehringer ingelheim
boston
What
medicines
6
×
announced
deal
drug
bets
bio
ceo
cholesterol
ipo
latest
medco
medicine
new
sanofi
aces
acquire
acquisitions
agreed
backs
big
billion
brings
cancer
cash
click
collabs
comes
companies
company
company’s
compound
course
covid
cut
daniel
date
development
digital
discover
effective
Language
unset
Current search:
sanofi
×
medicines
×
" new york top stories "
×
@xconomy.com
4 years ago
Bio Roundup: Gilead’s $4.9B Deal, COVID-19 Collabs, IPO Plans & More
@xconomy.com
4 years ago
Schrödinger Sets Course for IPO to Support Growing Internal Pipeline
@xconomy.com
4 years ago
Novartis to Acquire MedCo and FDA-Ready Cholesterol Drug for $9.7B
@xconomy.com
4 years ago
As Cholesterol Drug Aces Big Test, MedCo CEO Open to Flexible Pricing
@xconomy.com
5 years ago
Sanofi Backs Click Therapeutics as Digital Medicines Gain Momentum
@xconomy.com
5 years ago
With $45M Translate Bio Deal, Sanofi Bets Again on mRNA Vaccines